Skip to main content
. 2020 Nov 3;26(4):484–502. doi: 10.1177/2472555220965528

Figure 2.

Figure 2.

Von Hippel–Lindau (VHL)-based and cereblon (CRBN)-based small-molecule proteolysis-targeting chimeras (PROTACs). (A) Exemplified structures of VHL ligands and the PROTACs composed of them: VH032,24,26 VH101,25 VH298,25,26 MZ1,4 PROTAC_ RIPK2,27 PROTAC_ ERRα,27 ARD-266,137 VZ185,77 and ACBI1.138 (B) Exemplified structures of thalidomide and PROTACs composed of CRBN ligands: thalidomide,28 dBET1,3 dFKBP12,3 QCA570,139 PROTAC6,140 ZNL-02-096,141 and d9A-2.142